EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study

Beatriz Barreto-Duarte, Klauss Villalva-Serra, João P Miguez-Pinto, Mariana Araújo-Pereira, Vanessa M S Campos, Gabriela Rosier, Betânia M F Nogueira, Artur T L Queiroz, Valeria C Rolla, Marcelo Cordeiro-Santos iD, Afrânio L Kritski, Leonardo Martinez und 4 weitere

Open Forum Infectious Diseases · 30.07.2024 · 11 (8)

DOI: 10.1093/ofid/ofae416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 18.07.2024. Verfasst von Beatriz Barreto-Duarte und 15 weiteren Autor:innen. Beteiligte Einrichtung: Curso de Medicina, Universidade Salvador, Salvador, Brazil. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Intramural Research Program of the, Fundação Oswaldo Cruz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adherence to anti-tuberculosis treatment (ATT) in Brazil remains a challenge in achieving the goals set by the World Health Organization (WHO). Patients who are lost to follow-up during treatment pose a significant public health problem. This study aimed to investigate the factors associated with unfavorable ATT outcomes among those undergoing retreatment in Brazil.

Methods

We conducted an observational study of patients aged ≥18 years with tuberculosis (TB) reported to the Brazilian National Notifiable Disease Information System between 2015 and 2022. Clinical and epidemiologic variables were compared between the study groups (new cases and retreatment). Regression models identified variables associated with unfavorable outcomes.

Results

Among 743 823 reported TB cases in the study period, 555 632 cases were eligible, consisting of 462 061 new cases and 93 571 undergoing retreatments (44 642 recurrent and 48 929 retreatments after loss to follow-up [RLTFU]). RLTFU (odds ratio [OR], 3.96 [95% confidence interval {CI}, 3.83–4.1]) was a significant risk factor for any type of unfavorable ATT. Furthermore, RLTFU (OR, 4.93 [95% CI, 4.76–5.11]) was the main risk factor for subsequent LTFU. For death, aside from advanced age, living with HIV (OR, 6.28 [95% CI, 6.03–6.54]) was the top risk factor.

Conclusions

Retreatment is a substantial risk factor for unfavorable ATT outcomes, especially after LTFU. The rates of treatment success in RLTFU are distant from the WHO End TB Strategy targets throughout Brazil. These findings underscore the need for targeted interventions to improve treatment adherence and outcomes in persons who experience RLTFU.

Schlagwörter

Stichwörter der Autor:innen

epidemiologyloss to follow-upretreatmenttreatment outcometuberculosis

Autor:innen und Institutionen

  • Curso de Medicina, Universidade Salvador, Salvador, Brazil.
  • Programa Pós-graduação de Clínica Médica, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Institute for Research in Priority Populations, Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.
  • Instituto de Pesquisa Clínica e Translacional, Faculdade Zarns, Clariens Educação, Salvador, Brazil.
  • Laboratório de Pesquisa Clínica e Translacional, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
  • Programa de Pós-Graduação em Medicina e Saúde Humana, Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil.

ORCID-Profile: Marcelo Cordeiro-Santos, Peter F Rebeiro, Timothy R Sterling, Bruno B Andrade

Förderung

  • NIAID NIH HHS
  • Intramural Research Program of the
  • Fundação Oswaldo Cruz
  • Intramural Research Program of the Fundação José Silveira
  • Departamento de Ciência e Tecnologia
  • Secretaria de Ciência e Tecnologia
  • Ministério da Saúde
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Barreto-Duarte, B., Villalva-Serra, K., Miguez-Pinto, J. P., Araújo-Pereira, M., Campos, V. M. S., Rosier, G., Nogueira, B. M. F., Queiroz, A. T. L., Rolla, V. C., Cordeiro-Santos, M., Kritski, A. L., Martinez, L., Rebeiro, P. F., Sterling, T. R., Rodrigues, M. M., & Andrade, B. B. (2024). Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study. Open Forum Infectious Diseases, 11(8). https://doi.org/10.1093/ofid/ofae416

Vancouver

Barreto-Duarte B, Villalva-Serra K, Miguez-Pinto JP, Araújo-Pereira M, Campos VMS, Rosier G, et al. Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study. Open Forum Infectious Diseases. 2024;11(8). doi:10.1093/ofid/ofae416

BibTeX
@article{BarretoDuarte2024,
  author = {Barreto-Duarte, Beatriz and Villalva-Serra, Klauss and Miguez-Pinto, João P and Araújo-Pereira, Mariana and Campos, Vanessa M S and Rosier, Gabriela and Nogueira, Betânia M F and Queiroz, Artur T L and Rolla, Valeria C and Cordeiro-Santos, Marcelo and Kritski, Afrânio L and Martinez, Leonardo and Rebeiro, Peter F and Sterling, Timothy R and Rodrigues, Moreno M and Andrade, Bruno B},
  title = {Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study},
  journal = {Open Forum Infectious Diseases},
  year = {2024},
  volume = {11},
  number = {8},
  doi = {10.1093/ofid/ofae416}
}
Kostenlos starten →